Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-02-04

Clinical Trial Update: An Open Label, Exploratory Study to Investigate the Treatment Effect of Glatiramer Acetate on Girls Woth Rett Syndrome [Phase 1]

View source ↗

Summary

Open-label Phase 1 exploratory trial investigating the treatment effect of glatiramer acetate in girls with Rett syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GLATIRAMER ACETATE (GLATIRAMER ACETATE)

Snippet

Sponsor: Sheba Medical Center | Conditions: Rett Syndrome | Phase 1 | Status: UNKNOWN